Digestive tract pathology

Sebastiano Biondo Aglio

PRINCIPAL INVESTIGATORS
  • Ricardo Frago Montanuy
  • Jordi Guardiola Capon
  • Josep Maria Botargues Bote
  • Marta Climent Agusti
CLINICAL RESEARCHERS
  • Jaime Lopez Borao
  • Carla Bettonica Larrañaga
  • Claudia Lourdes Arajol Gonzalez
  • Ana Berrozpe Lopez
  • Thomas Golda
  • Loris Trenti
  • Kristel Mils Julià
  • Zoilo Madrazo Gonzalez
SCIENTIFIC SUPPORT
  • Blau Camps Aler
Translational Medicine
Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention

Scientific production

35

PAPERS

Impact factor: 134,643

2 PUBLICATIONS IN FIRST DECILE

9 PUBLICATIONS IN FIRST QUARTILE

Selected publications

  • Espin Basany, Eloy; Solis-Pena, Alejandro; Pellino, Gianluca; Kreisler, Esther; Fraccalvieri, Domenico; Muinelo-Lorenzo, Manuel; Maseda-Diaz, Olga; Maria Garcia-Gonzalez, Jose; Santamaria-Olabarrieta, Marta; Codina-Cazador, Antonio; Biondo, Sebastiano. Preoperative oral antibiotics and surgical-site infections in colon surgery (ORALEV): a multicentre, single-blind, pragmatic, randomised controlled trial. LANCET GASTROENTEROLOGY & HEPATOLOGY. 10.1016/S2468-1253(20)30075-3
  • Biondo, Sebastiano; Trenti, Loris; Espin, Eloy; Bianco, Francesco; Barrios, Oriana; Falato, Armando; De Franciscis, Silvia; Solis, Alejandro; Kreisler, Esther. Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis for Low Rectal Cancer A Randomized Clinical Trial. JAMA SURGERY. 10.1001/jamasurg.2020.1625
  • Calafat, Margalida; Manosa, Miriam; Mesonero, Francisco; Guardiola, Jordi; Minguez, Miguel; Nos, Pilar; Vera, Isabel; Taxonera, Carlos; Iglesias, Eva; Ricart, Elena; Gisbert, Javier P.; Calvet, Xavier; Garcia-Lopez, Santiago; Monfort, David; Perez Calle, Jose Lazaro; Riestra, Sabino; Gomollon, Fernando; Garcia-Planella, Esther; Bermejo, Fernando; Hernandez, Vicent; Dolores Martin-Arranz, Maria; Gutierrez, Ana; Torres, Paola; Canete, Fiorella; Domenech, Eugeni. Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry. JOURNAL OF CROHNS & COLITIS. 10.1093/ecco-jcc/jjaa055
  • Eliadou, E; Moleiro, J; Ribaldone, DG; Astegiano, M; Rothfuss, K; Taxonera, C; Ghalim, F; Carbonnel, F; Verstockt, B; Festa, S; Maia, L; Berrozpe, A; Zagorowicz, E; Savarino, E; Ellul, P; Vavricka, SR; Calvo, M; Koutroubakis, I; Hoentjen, F; Salazar, LF; Callela, F; Pizarro, FC; Soufleris, K; Sonnenberg, E; Cavicchi, M; Wypych, J; Hommel, C; Ghiani, A; Fiorino, G. Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients. JOURNAL OF CROHNS & COLITIS. 10.1093/ecco-jcc/jjz165
  • Duenas, Nuria; Navarro, Matilde; Teule, Alex; Solanes, Ares; Salinas, Monica; Iglesias, Silvia; Munte, Elisabet; Ponce, Jordi; Guardiola, Jordi; Kreisler, Esther; Carballas, Elvira; Cuadrado, Marta; Matias-Guiu, Xavier; de la Ossa, Napoleon; Lop, Joan; Lazaro, Conxi; Capella, Gabriel; Pineda, Marta; Brunet, Joan. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. CANCERS. 10.3390/cancers12113419

Research highlights

PROJECTS

3 Ongoing projects
2 Granted projects

 

11 Ongoing clinical trials

PUBLISHED WORKS

1 Defended thesis

3 Clinical guidelines

Selected projects

  • Entyvio (vedolizumab) long-term safety study: an international observational prospecive cohort study comparing vedolizumab to other biologic agents in patients with ulcerative colitis or crohn’s disease (2018 – 2024) PI: Guardiola Capón, Jordi. Funder: MAPI SAS.
  • Estudio para la validación de un perfil de micro rnas como biomarcadores para el cribado de cáncer colorectal (2017 – 2025) PI: Guardiola Capó, Jordi. Funder: Advanced Marker Discovery, S.L..
  • Estudio de estrategias de mantenimiento comparando práctica clínica habitual frente a ‘tret to target’ en pacientes con enfermedad de crohn tratados con ustekinumab (2017 – 2026) PI: Guardiola Capó, Jordi. Funder: Janssen-Cilag, S.A..
  • Estudio multicéntrico aleatorizado, doble ciego y controlado con placebo, con tratamiento de mantenimiento durante 52 semanas y una extensión abierta para evaluar la eficacia y la seguridad de risankizumab en sujetos con enfermedad de crohn que respondan al tratamiento de inducción en los estudios M16-006 O M15-991 (2019 – 2020) PI: Guardiola Capón, Jordi. Funder: ABBVIE SPAIN, S.L.U..
  • Rifaximin delayed release (400 mg. tablet) for the preventin of recurrent acute diverticulitis and diverticular complications. a phase II, multicenter, double-blind, placebo-controlled, randomized clinical trial. (THE ROAD TRIAL) (2018 – 2020) PI: Biondo Aglio, Sebastiano. Funder: LB RESEARCH SRL.